ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leuprolide Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-12Y5964
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Leuprolide Market Insights and Forecast to 2028
BUY CHAPTERS

Global Leuprolide Market Research Report 2025

Code: QYRE-Auto-12Y5964
Report
September 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Tolmar Pharmaceuticals
Sanofi
TEVA
Sandoz(Novartis)
Sun Pharmaceutical
AbbVie
Bayer
Takeda
Beijing Boente Pharmaceutical
Livzon Pharmaceutical
Selleck
Hangzhou Peptide Biochemical
Chengdu Shenguo Biological Pharmaceutical
SciAnda Pharma
Daewoong Co Ltd
GP Pharm
Enteris BioPharma
Chong Kun Dang
Leadiant Biosciences
Hikma Pharmaceuticals
Lee Pharma
Hanall

Leuprolide Market

The global market for Leuprolide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer"s disease.
North American market for Leuprolide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Leuprolide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Leuprolide in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Leuprolide include TOLMAR PHARMACEUTICALS, Sanofi, Teva, Sandoz (Novartis), Sun Pharmaceutical, AbbVie, Bayer, Takeda, Beijing Boente Pharmaceutical, Livzon Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Leuprolide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leuprolide.
The Leuprolide market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Leuprolide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leuprolide companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Leuprolide Market Report

Report Metric Details
Report Name Leuprolide Market
Segment by Type
  • Subcutaneous
  • Topical
Segment by Application
  • Breast Cancer
  • Endometriosis
  • Precocious Puberty
  • Prostate Cancer
  • Uterine Fibrosis
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company TOLMAR PHARMACEUTICALS, Sanofi, Teva, Sandoz (Novartis), Sun Pharmaceutical, AbbVie, Bayer, Takeda, Beijing Boente Pharmaceutical, Livzon Pharmaceutical, Selleck, Hangzhou Peptide Biochemical, Chengdu Shenguo Biological Pharmaceutical, SciAnda Pharma, Daewoong, GP Pharm, Enteris BioPharma, Chong Kun Dang, Leadiant Biosciences, Hikma Pharmaceuticals, Lee Pharma, Hanall
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Leuprolide company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Leuprolide Market report?

Ans: The main players in the Leuprolide Market are TOLMAR PHARMACEUTICALS, Sanofi, Teva, Sandoz (Novartis), Sun Pharmaceutical, AbbVie, Bayer, Takeda, Beijing Boente Pharmaceutical, Livzon Pharmaceutical, Selleck, Hangzhou Peptide Biochemical, Chengdu Shenguo Biological Pharmaceutical, SciAnda Pharma, Daewoong, GP Pharm, Enteris BioPharma, Chong Kun Dang, Leadiant Biosciences, Hikma Pharmaceuticals, Lee Pharma, Hanall

What are the Application segmentation covered in the Leuprolide Market report?

Ans: The Applications covered in the Leuprolide Market report are Breast Cancer, Endometriosis, Precocious Puberty, Prostate Cancer, Uterine Fibrosis, Other

What are the Type segmentation covered in the Leuprolide Market report?

Ans: The Types covered in the Leuprolide Market report are Subcutaneous, Topical

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leuprolide Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Subcutaneous
1.2.3 Topical
1.3 Market by Application
1.3.1 Global Leuprolide Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Endometriosis
1.3.4 Precocious Puberty
1.3.5 Prostate Cancer
1.3.6 Uterine Fibrosis
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leuprolide Market Perspective (2020-2031)
2.2 Global Leuprolide Growth Trends by Region
2.2.1 Global Leuprolide Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Leuprolide Historic Market Size by Region (2020-2025)
2.2.3 Leuprolide Forecasted Market Size by Region (2026-2031)
2.3 Leuprolide Market Dynamics
2.3.1 Leuprolide Industry Trends
2.3.2 Leuprolide Market Drivers
2.3.3 Leuprolide Market Challenges
2.3.4 Leuprolide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leuprolide Players by Revenue
3.1.1 Global Top Leuprolide Players by Revenue (2020-2025)
3.1.2 Global Leuprolide Revenue Market Share by Players (2020-2025)
3.2 Global Leuprolide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Leuprolide Revenue
3.4 Global Leuprolide Market Concentration Ratio
3.4.1 Global Leuprolide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leuprolide Revenue in 2024
3.5 Global Key Players of Leuprolide Head office and Area Served
3.6 Global Key Players of Leuprolide, Product and Application
3.7 Global Key Players of Leuprolide, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Leuprolide Breakdown Data by Type
4.1 Global Leuprolide Historic Market Size by Type (2020-2025)
4.2 Global Leuprolide Forecasted Market Size by Type (2026-2031)
5 Leuprolide Breakdown Data by Application
5.1 Global Leuprolide Historic Market Size by Application (2020-2025)
5.2 Global Leuprolide Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Leuprolide Market Size (2020-2031)
6.2 North America Leuprolide Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Leuprolide Market Size by Country (2020-2025)
6.4 North America Leuprolide Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leuprolide Market Size (2020-2031)
7.2 Europe Leuprolide Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Leuprolide Market Size by Country (2020-2025)
7.4 Europe Leuprolide Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leuprolide Market Size (2020-2031)
8.2 Asia-Pacific Leuprolide Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Leuprolide Market Size by Region (2020-2025)
8.4 Asia-Pacific Leuprolide Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leuprolide Market Size (2020-2031)
9.2 Latin America Leuprolide Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Leuprolide Market Size by Country (2020-2025)
9.4 Latin America Leuprolide Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leuprolide Market Size (2020-2031)
10.2 Middle East & Africa Leuprolide Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Leuprolide Market Size by Country (2020-2025)
10.4 Middle East & Africa Leuprolide Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 TOLMAR PHARMACEUTICALS
11.1.1 TOLMAR PHARMACEUTICALS Company Details
11.1.2 TOLMAR PHARMACEUTICALS Business Overview
11.1.3 TOLMAR PHARMACEUTICALS Leuprolide Introduction
11.1.4 TOLMAR PHARMACEUTICALS Revenue in Leuprolide Business (2020-2025)
11.1.5 TOLMAR PHARMACEUTICALS Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Leuprolide Introduction
11.2.4 Sanofi Revenue in Leuprolide Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Leuprolide Introduction
11.3.4 Teva Revenue in Leuprolide Business (2020-2025)
11.3.5 Teva Recent Development
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Details
11.4.2 Sandoz (Novartis) Business Overview
11.4.3 Sandoz (Novartis) Leuprolide Introduction
11.4.4 Sandoz (Novartis) Revenue in Leuprolide Business (2020-2025)
11.4.5 Sandoz (Novartis) Recent Development
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Details
11.5.2 Sun Pharmaceutical Business Overview
11.5.3 Sun Pharmaceutical Leuprolide Introduction
11.5.4 Sun Pharmaceutical Revenue in Leuprolide Business (2020-2025)
11.5.5 Sun Pharmaceutical Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Leuprolide Introduction
11.6.4 AbbVie Revenue in Leuprolide Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Leuprolide Introduction
11.7.4 Bayer Revenue in Leuprolide Business (2020-2025)
11.7.5 Bayer Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Leuprolide Introduction
11.8.4 Takeda Revenue in Leuprolide Business (2020-2025)
11.8.5 Takeda Recent Development
11.9 Beijing Boente Pharmaceutical
11.9.1 Beijing Boente Pharmaceutical Company Details
11.9.2 Beijing Boente Pharmaceutical Business Overview
11.9.3 Beijing Boente Pharmaceutical Leuprolide Introduction
11.9.4 Beijing Boente Pharmaceutical Revenue in Leuprolide Business (2020-2025)
11.9.5 Beijing Boente Pharmaceutical Recent Development
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Details
11.10.2 Livzon Pharmaceutical Business Overview
11.10.3 Livzon Pharmaceutical Leuprolide Introduction
11.10.4 Livzon Pharmaceutical Revenue in Leuprolide Business (2020-2025)
11.10.5 Livzon Pharmaceutical Recent Development
11.11 Selleck
11.11.1 Selleck Company Details
11.11.2 Selleck Business Overview
11.11.3 Selleck Leuprolide Introduction
11.11.4 Selleck Revenue in Leuprolide Business (2020-2025)
11.11.5 Selleck Recent Development
11.12 Hangzhou Peptide Biochemical
11.12.1 Hangzhou Peptide Biochemical Company Details
11.12.2 Hangzhou Peptide Biochemical Business Overview
11.12.3 Hangzhou Peptide Biochemical Leuprolide Introduction
11.12.4 Hangzhou Peptide Biochemical Revenue in Leuprolide Business (2020-2025)
11.12.5 Hangzhou Peptide Biochemical Recent Development
11.13 Chengdu Shenguo Biological Pharmaceutical
11.13.1 Chengdu Shenguo Biological Pharmaceutical Company Details
11.13.2 Chengdu Shenguo Biological Pharmaceutical Business Overview
11.13.3 Chengdu Shenguo Biological Pharmaceutical Leuprolide Introduction
11.13.4 Chengdu Shenguo Biological Pharmaceutical Revenue in Leuprolide Business (2020-2025)
11.13.5 Chengdu Shenguo Biological Pharmaceutical Recent Development
11.14 SciAnda Pharma
11.14.1 SciAnda Pharma Company Details
11.14.2 SciAnda Pharma Business Overview
11.14.3 SciAnda Pharma Leuprolide Introduction
11.14.4 SciAnda Pharma Revenue in Leuprolide Business (2020-2025)
11.14.5 SciAnda Pharma Recent Development
11.15 Daewoong
11.15.1 Daewoong Company Details
11.15.2 Daewoong Business Overview
11.15.3 Daewoong Leuprolide Introduction
11.15.4 Daewoong Revenue in Leuprolide Business (2020-2025)
11.15.5 Daewoong Recent Development
11.16 GP Pharm
11.16.1 GP Pharm Company Details
11.16.2 GP Pharm Business Overview
11.16.3 GP Pharm Leuprolide Introduction
11.16.4 GP Pharm Revenue in Leuprolide Business (2020-2025)
11.16.5 GP Pharm Recent Development
11.17 Enteris BioPharma
11.17.1 Enteris BioPharma Company Details
11.17.2 Enteris BioPharma Business Overview
11.17.3 Enteris BioPharma Leuprolide Introduction
11.17.4 Enteris BioPharma Revenue in Leuprolide Business (2020-2025)
11.17.5 Enteris BioPharma Recent Development
11.18 Chong Kun Dang
11.18.1 Chong Kun Dang Company Details
11.18.2 Chong Kun Dang Business Overview
11.18.3 Chong Kun Dang Leuprolide Introduction
11.18.4 Chong Kun Dang Revenue in Leuprolide Business (2020-2025)
11.18.5 Chong Kun Dang Recent Development
11.19 Leadiant Biosciences
11.19.1 Leadiant Biosciences Company Details
11.19.2 Leadiant Biosciences Business Overview
11.19.3 Leadiant Biosciences Leuprolide Introduction
11.19.4 Leadiant Biosciences Revenue in Leuprolide Business (2020-2025)
11.19.5 Leadiant Biosciences Recent Development
11.20 Hikma Pharmaceuticals
11.20.1 Hikma Pharmaceuticals Company Details
11.20.2 Hikma Pharmaceuticals Business Overview
11.20.3 Hikma Pharmaceuticals Leuprolide Introduction
11.20.4 Hikma Pharmaceuticals Revenue in Leuprolide Business (2020-2025)
11.20.5 Hikma Pharmaceuticals Recent Development
11.21 Lee Pharma
11.21.1 Lee Pharma Company Details
11.21.2 Lee Pharma Business Overview
11.21.3 Lee Pharma Leuprolide Introduction
11.21.4 Lee Pharma Revenue in Leuprolide Business (2020-2025)
11.21.5 Lee Pharma Recent Development
11.22 Hanall
11.22.1 Hanall Company Details
11.22.2 Hanall Business Overview
11.22.3 Hanall Leuprolide Introduction
11.22.4 Hanall Revenue in Leuprolide Business (2020-2025)
11.22.5 Hanall Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Tolmar Pharmaceuticals
Sanofi
TEVA
Sandoz(Novartis)
Sun Pharmaceutical
AbbVie
Bayer
Takeda
Beijing Boente Pharmaceutical
Livzon Pharmaceutical
Selleck
Hangzhou Peptide Biochemical
Chengdu Shenguo Biological Pharmaceutical
SciAnda Pharma
Daewoong Co Ltd
GP Pharm
Enteris BioPharma
Chong Kun Dang
Leadiant Biosciences
Hikma Pharmaceuticals
Lee Pharma
Hanall
List of Tables
 Table 1. Global Leuprolide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Subcutaneous
 Table 3. Key Players of Topical
 Table 4. Global Leuprolide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Leuprolide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Leuprolide Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Leuprolide Market Share by Region (2020-2025)
 Table 8. Global Leuprolide Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Leuprolide Market Share by Region (2026-2031)
 Table 10. Leuprolide Market Trends
 Table 11. Leuprolide Market Drivers
 Table 12. Leuprolide Market Challenges
 Table 13. Leuprolide Market Restraints
 Table 14. Global Leuprolide Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Leuprolide Market Share by Players (2020-2025)
 Table 16. Global Top Leuprolide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leuprolide as of 2024)
 Table 17. Ranking of Global Top Leuprolide Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Leuprolide Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Leuprolide, Headquarters and Area Served
 Table 20. Global Key Players of Leuprolide, Product and Application
 Table 21. Global Key Players of Leuprolide, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Leuprolide Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Leuprolide Revenue Market Share by Type (2020-2025)
 Table 25. Global Leuprolide Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Leuprolide Revenue Market Share by Type (2026-2031)
 Table 27. Global Leuprolide Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Leuprolide Revenue Market Share by Application (2020-2025)
 Table 29. Global Leuprolide Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Leuprolide Revenue Market Share by Application (2026-2031)
 Table 31. North America Leuprolide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Leuprolide Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Leuprolide Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Leuprolide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Leuprolide Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Leuprolide Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Leuprolide Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Leuprolide Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Leuprolide Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Leuprolide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Leuprolide Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Leuprolide Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Leuprolide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Leuprolide Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Leuprolide Market Size by Country (2026-2031) & (US$ Million)
 Table 46. TOLMAR PHARMACEUTICALS Company Details
 Table 47. TOLMAR PHARMACEUTICALS Business Overview
 Table 48. TOLMAR PHARMACEUTICALS Leuprolide Product
 Table 49. TOLMAR PHARMACEUTICALS Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 50. TOLMAR PHARMACEUTICALS Recent Development
 Table 51. Sanofi Company Details
 Table 52. Sanofi Business Overview
 Table 53. Sanofi Leuprolide Product
 Table 54. Sanofi Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 55. Sanofi Recent Development
 Table 56. Teva Company Details
 Table 57. Teva Business Overview
 Table 58. Teva Leuprolide Product
 Table 59. Teva Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 60. Teva Recent Development
 Table 61. Sandoz (Novartis) Company Details
 Table 62. Sandoz (Novartis) Business Overview
 Table 63. Sandoz (Novartis) Leuprolide Product
 Table 64. Sandoz (Novartis) Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 65. Sandoz (Novartis) Recent Development
 Table 66. Sun Pharmaceutical Company Details
 Table 67. Sun Pharmaceutical Business Overview
 Table 68. Sun Pharmaceutical Leuprolide Product
 Table 69. Sun Pharmaceutical Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 70. Sun Pharmaceutical Recent Development
 Table 71. AbbVie Company Details
 Table 72. AbbVie Business Overview
 Table 73. AbbVie Leuprolide Product
 Table 74. AbbVie Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 75. AbbVie Recent Development
 Table 76. Bayer Company Details
 Table 77. Bayer Business Overview
 Table 78. Bayer Leuprolide Product
 Table 79. Bayer Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 80. Bayer Recent Development
 Table 81. Takeda Company Details
 Table 82. Takeda Business Overview
 Table 83. Takeda Leuprolide Product
 Table 84. Takeda Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 85. Takeda Recent Development
 Table 86. Beijing Boente Pharmaceutical Company Details
 Table 87. Beijing Boente Pharmaceutical Business Overview
 Table 88. Beijing Boente Pharmaceutical Leuprolide Product
 Table 89. Beijing Boente Pharmaceutical Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 90. Beijing Boente Pharmaceutical Recent Development
 Table 91. Livzon Pharmaceutical Company Details
 Table 92. Livzon Pharmaceutical Business Overview
 Table 93. Livzon Pharmaceutical Leuprolide Product
 Table 94. Livzon Pharmaceutical Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 95. Livzon Pharmaceutical Recent Development
 Table 96. Selleck Company Details
 Table 97. Selleck Business Overview
 Table 98. Selleck Leuprolide Product
 Table 99. Selleck Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 100. Selleck Recent Development
 Table 101. Hangzhou Peptide Biochemical Company Details
 Table 102. Hangzhou Peptide Biochemical Business Overview
 Table 103. Hangzhou Peptide Biochemical Leuprolide Product
 Table 104. Hangzhou Peptide Biochemical Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 105. Hangzhou Peptide Biochemical Recent Development
 Table 106. Chengdu Shenguo Biological Pharmaceutical Company Details
 Table 107. Chengdu Shenguo Biological Pharmaceutical Business Overview
 Table 108. Chengdu Shenguo Biological Pharmaceutical Leuprolide Product
 Table 109. Chengdu Shenguo Biological Pharmaceutical Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 110. Chengdu Shenguo Biological Pharmaceutical Recent Development
 Table 111. SciAnda Pharma Company Details
 Table 112. SciAnda Pharma Business Overview
 Table 113. SciAnda Pharma Leuprolide Product
 Table 114. SciAnda Pharma Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 115. SciAnda Pharma Recent Development
 Table 116. Daewoong Company Details
 Table 117. Daewoong Business Overview
 Table 118. Daewoong Leuprolide Product
 Table 119. Daewoong Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 120. Daewoong Recent Development
 Table 121. GP Pharm Company Details
 Table 122. GP Pharm Business Overview
 Table 123. GP Pharm Leuprolide Product
 Table 124. GP Pharm Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 125. GP Pharm Recent Development
 Table 126. Enteris BioPharma Company Details
 Table 127. Enteris BioPharma Business Overview
 Table 128. Enteris BioPharma Leuprolide Product
 Table 129. Enteris BioPharma Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 130. Enteris BioPharma Recent Development
 Table 131. Chong Kun Dang Company Details
 Table 132. Chong Kun Dang Business Overview
 Table 133. Chong Kun Dang Leuprolide Product
 Table 134. Chong Kun Dang Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 135. Chong Kun Dang Recent Development
 Table 136. Leadiant Biosciences Company Details
 Table 137. Leadiant Biosciences Business Overview
 Table 138. Leadiant Biosciences Leuprolide Product
 Table 139. Leadiant Biosciences Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 140. Leadiant Biosciences Recent Development
 Table 141. Hikma Pharmaceuticals Company Details
 Table 142. Hikma Pharmaceuticals Business Overview
 Table 143. Hikma Pharmaceuticals Leuprolide Product
 Table 144. Hikma Pharmaceuticals Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 145. Hikma Pharmaceuticals Recent Development
 Table 146. Lee Pharma Company Details
 Table 147. Lee Pharma Business Overview
 Table 148. Lee Pharma Leuprolide Product
 Table 149. Lee Pharma Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 150. Lee Pharma Recent Development
 Table 151. Hanall Company Details
 Table 152. Hanall Business Overview
 Table 153. Hanall Leuprolide Product
 Table 154. Hanall Revenue in Leuprolide Business (2020-2025) & (US$ Million)
 Table 155. Hanall Recent Development
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources
 Table 159. Authors List of This Report


List of Figures
 Figure 1. Leuprolide Picture
 Figure 2. Global Leuprolide Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Leuprolide Market Share by Type: 2024 VS 2031
 Figure 4. Subcutaneous Features
 Figure 5. Topical Features
 Figure 6. Global Leuprolide Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Leuprolide Market Share by Application: 2024 VS 2031
 Figure 8. Breast Cancer Case Studies
 Figure 9. Endometriosis Case Studies
 Figure 10. Precocious Puberty Case Studies
 Figure 11. Prostate Cancer Case Studies
 Figure 12. Uterine Fibrosis Case Studies
 Figure 13. Other Case Studies
 Figure 14. Leuprolide Report Years Considered
 Figure 15. Global Leuprolide Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Leuprolide Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Leuprolide Market Share by Region: 2024 VS 2031
 Figure 18. Global Leuprolide Market Share by Players in 2024
 Figure 19. Global Top Leuprolide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leuprolide as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Leuprolide Revenue in 2024
 Figure 21. North America Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Leuprolide Market Share by Country (2020-2031)
 Figure 23. United States Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Leuprolide Market Share by Country (2020-2031)
 Figure 27. Germany Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Leuprolide Market Share by Region (2020-2031)
 Figure 35. China Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Leuprolide Market Share by Country (2020-2031)
 Figure 43. Mexico Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Leuprolide Market Share by Country (2020-2031)
 Figure 47. Turkey Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Leuprolide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. TOLMAR PHARMACEUTICALS Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 51. Sanofi Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 52. Teva Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 53. Sandoz (Novartis) Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 54. Sun Pharmaceutical Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 55. AbbVie Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 56. Bayer Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 57. Takeda Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 58. Beijing Boente Pharmaceutical Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 59. Livzon Pharmaceutical Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 60. Selleck Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 61. Hangzhou Peptide Biochemical Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 62. Chengdu Shenguo Biological Pharmaceutical Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 63. SciAnda Pharma Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 64. Daewoong Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 65. GP Pharm Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 66. Enteris BioPharma Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 67. Chong Kun Dang Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 68. Leadiant Biosciences Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 69. Hikma Pharmaceuticals Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 70. Lee Pharma Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 71. Hanall Revenue Growth Rate in Leuprolide Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Enanton Leucorin Acetate Market Research Report 2024
Global Leuprorelin Acetate Market Insights Forecast to 2030
Global Leuprorelin Drugs Market Research Report 2024
Global Leuprorelin Acetate Microspheres for Injection Market Research Report 2024
Global GnRHa Peptide Drugs Market Research Report 2024
Global Gonadotropin releasing Hormone Antagonists Market Research Report 2024
Global Gonadorelin Market Insights Forecast to 2030
Global GnRH Agonist Market Research Report 2024
Global GnRH Analogues Market Research Report 2024
Global Elagolix Drugs Market Research Report 2024
Global Triptorelin Acetate Market Insights Forecast to 2030
Goserelin Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luteinizing Hormone releasing Hormone Analogs Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gonadotropin releasing Hormone Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GnRH Receptor Antagonists Market Research Report 2024
Luteinizing Hormone releasing Hormone Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gonadotropin releasing Hormone Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Leupeptin Market Research Report 2024
Global Luteinizing Hormone Releasing Antagonist Market Research Report 2024
Global Nafarelin Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions